The significance of strong histone deacetylase 1 expression in the progression of prostate cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Histopathology

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2559.2011.03797.xPMID 21438903
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression

  2010cited by this paper
• Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth.

  2009cited by this paper
• Twist and p53 reciprocally regulate target genes via direct interaction

  2008cited by this paper
• Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

  2008influential reference
• Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.

  2008cited by this paper
• Twist promotes tumor cell growth through YB-1 expression.

  2008cited by this paper
• Expression profile of class I histone deacetylases in human cancer tissues.

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Histone deacetylases and cancer

  2007cited by this paper
• Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

  2006cited by this paper
• Histone modifications silence the GATA transcription factor genes in ovarian cancer

  2006cited by this paper
• Targeting epigenetic abnormalities with histone deacetylase inhibitors

  2006cited by this paper
• Differentiation of androgen-independent prostate cancer PC-3 cells is associated with increased nuclear factor-kappaB activity.

  2005cited by this paper
• Increased expression of histone deacetylase 2 is found in human gastric cancer

  2005cited by this paper
• Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells.

  2004cited by this paper
• Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer

  2004cited by this paper
• Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation.

  2003cited by this paper
• Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation

  2003cited by this paper
• Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

  2003cited by this paper
• Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression

  2002cited by this paper
• Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling

  2002cited by this paper
• Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphoblastic leukaemia

  2002cited by this paper
• Histone deacetylase and DNA methyltransferase in human prostate cancer.

  2001cited by this paper
• The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.

  2001cited by this paper
• Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes

  2001cited by this paper
• Global cancer statistics in the year 2000.

  2001cited by this paper
• Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.

  2000cited by this paper
• Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects*

  1999cited by this paper
• Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

  1998cited by this paper
• Epigenetic Mechanisms for Progression of Prostate Cancer

  1998cited by this paper
• Cancer statistics

  1989cited by this paper

• The novel selective HDAC1 inhibitor ZJH-1 exhibits potent antitumor activity in castration-resistant prostate cancer, potentially involving HSP90AA1.

  2025cites this paper
• Matrix metalloproteinases targeting in prostate cancer.

  2024cites this paper
• Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

  2023cites this paper
• Dual HDAC/BRD4 inhibitors against cancer

  2021cites this paper
• Molecular Carcinogenesis

  2019cites this paper
• ORGANOSULFUR GARLIC-DERIVED COMPOUNDS INDUCE ABCA 1 GENE EXPRESSION IN RAW 264 . 7 CELLS

  2018cites this paper
• Histonedeacetylase 1 mRNA has elevated expression in clinical specimen of bladder cancer.

  2018cites this paper
• Angiogenesis and Cardiovascular Diseases: The Emerging Role of HDACs

  2017cites this paper
• Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells

  2017cites this paper
• Genetic and epigenetic alterations as serum markers for cancer detection

  2017cites this paper
• Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents.

  2017cites this paper
• HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer.

  2015cites this paper
• Targeting Histone Deacetylases in Diseases: Where Are We?

  2015cites this paper
• Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression.

  2015cites this paper
• Phosphoprotein phosphatase 1-interacting proteins as therapeutic targets in prostate cancer

  2014cites this paper
• Mutagenesis Studies of the 14 Å Internal Cavity of Histone Deacetylase 1: Insights toward the Acetate-Escape Hypothesis and Selective Inhibitor Design

  2014cites this paper
• The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease

  2014cites this paper
• Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing

  2013cites this paper
• Identification of an Intrinsic Determinant Critical for Maspin Subcellular Localization and Function

  2013cites this paper
• KAT5 and KAT6B are in positive regulation on cell proliferation of prostate cancer through PI3K-AKT signaling.

  2013cites this paper
• PHENOTYPIC IMPACT OF ETV4 OVEREXPRESSION IN PROSTATE CARCINOGENESIS

  2012cites this paper
• Histone deacetylase 1 and 2 in mesenchymal tumors

  2012cites this paper
• Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: In vitro and in vivo study

  2012cites this paper
• Assessment of enoxacin effect on cancer growth and microrna expression in prostate cell lines

  2012cites this paper
• Investigation of Novel Progression-related Methylation Events and HOXD Genes in Prostate Cancer

  2012cites this paper
• HDAC1 Expression in Invasive Ductal Carcinoma of the Breast and Its Value as a Good Prognostic Factor

  2012cites this paper
• Epigenetics in Prostate Cancer

  2011cites this paper